什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001535610
申报总市值
US$1.1亿
US$1.1亿
42 檔
13.9%
根据最新整理的 13F 季度数据集,Sabby Management, LLC 于 Q3 2024 结束时的管理资产规模为 US$1.1亿。该机构在本季度申报了 42 档美股持仓,呈现出该时期的主要投资地图。
Sabby Management, LLC 在 Q3 2024 进行了结构性的板块轮动与仓位换股。在开立 23 个全新仓位及加仓 10 档持股的同时,亦同步清仓 20 档并减仓 8 档标的。
在资产配置集中度方面,Sabby Management, LLC 的前 5 大核心持股(包含 CORE SCIENTIFIC INC NEW, VANI, BIT DIGITAL INC 等)合计占整体申报市值的 13.9%,反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Core Scientific Inc New | 股票-其他 | 40.50% | — | +27.17% | |
| 2 | VANI | Vivani Medical Inc | 股票-其他 | 11.32% | — | +0.09% | |
| 3 | ✓ | Bit Digital Inc | 股票-其他 | 9.96% | — | +44.94% | |
| 4 | ✓ | Eos Energy Enterprises Inc | 股票-其他 | 4.36% | — | +531.51% | |
| 5 | ✓ | Volcon Inc | 股票-其他 | 3.66% | — | — | |
| 6 | HCWC | Healthy Choice Wellness CORP | 股票-其他 | 3.43% | — | — | |
| 7 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-大型股与成长 | 3.25% | +45.73% | +13.99% | |
| 8 | CLSNEUR | Imunon Inc | 股票-其他 | 2.93% | — | — | |
| 9 | CORZ | Core Scientific, Inc. | 股票-科技 | 2.26% | — | -15.18% | |
| 10 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-大型股与成长 | 1.95% | +13.85% | NEW | |
| 11 | ✓ | Ishares Tr | 股票-其他 | 1.88% | +11.16% | -25.29% | |
| 12 | CORZ | Core Scientific Inc | 股票-科技 | 1.83% | — | — | |
| 13 | ✓ | Checkpoint Therapeutics Inc | 股票-其他 | 1.79% | — | -34.97% | |
| 14 | ✓ | 股票-其他 | 1.69% | — | — | ||
| 15 | ✓ | Ensysce Biosciences Inc | 股票-其他 | 1.27% | — | +269.84% | |
| 16 | SCPX | Scorpius Holdings Inc | 股票-其他 | 1.13% | — | — | |
| 17 | ✓ | 股票-其他 | 0.96% | — | — | ||
| 18 | ATXI | Avenue Therapeutics Inc | 股票-其他 | 0.71% | — | +68.64% | |
| 19 | SNES | Senestech Inc | 股票-其他 | 0.65% | -3.82% | — | |
| 20 | ✓ | 股票-其他 | 0.60% | — | — | ||
| 21 | ✓ | Nrx Pharmaceuticals Inc | 股票-其他 | 0.59% | — | +44.91% | |
| 22 | ✓ | 股票-其他 | 0.57% | — | — | ||
| 23 | ✓ | Ishares Tr | 股票-其他 | 0.46% | +12.02% | NEW | |
| 24 | PHIO | Phio Pharmaceuticals CORP | 股票-其他 | 0.39% | — | — | |
| 25 | SIDU | Sidus Space Inc-cl A | 股票-其他 | 0.38% | +0.11% | NEW | |
| 26 | NRXP | Nrx Pharmaceuticals Inc | 股票-其他 | 0.27% | — | — | |
| 27 | VVOS | Vivos Therapeutics Inc | 股票-其他 | 0.24% | — | — | |
| 28 | ✓ | Bluejay Diagnostics Inc | 股票-其他 | 0.18% | — | — | |
| 29 | ✓ | Revelation Biosciences Inc | 股票-其他 | 0.16% | — | — | |
| 30 | ✓ | 股票-其他 | 0.16% | — | — | ||
| 31 | KPRX | Kiora Pharmaceuticals Inc | 股票-其他 | 0.08% | — | — | |
| 32 | ✓ | Globus Maritime Limited New | 股票-其他 | 0.08% | — | — | |
| 33 | SXTPW | 60 Degrees Pharma Inc-28 | 股票-其他 | 0.07% | — | -8.28% | |
| 34 | ✓ | Reviva Pharmaceutcls Hldgs Inc | 股票-其他 | 0.06% | — | — | |
| 35 | AMPGW | Amplitech Group Inc-cw26 | 股票-其他 | 0.04% | — | -40.68% | |
| 36 | ✓ | 股票-其他 | 0.03% | — | — | ||
| 37 | ✓ | Scilex Holding Co | 股票-其他 | 0.02% | — | — | |
| 38 | SCLXUSD | Scilex Holding Co | 股票-其他 | 0.02% | — | — | |
| 39 | ✓ | 股票-其他 | 0.01% | — | — | ||
| 40 | ✓ | Wearable Devices LTD | 股票-其他 | 0.01% | — | -33.34% | |
| 41 | EFTR | Effector Therapeutics Inc | 股票-其他 | 0.01% | — | -82.46% | |
| 42 | ✓ | Atossa Therapeutics Inc | 股票-其他 | 0.01% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ✓ | Core Scientific Inc New | +33% | +27.17% | 加仓 |
| 2 | ✓ | Bit Digital Inc | +8.1% | +44.94% | 加仓 |
| 3 | VANI | Vivani Medical Inc | +7.7% | +0.09% | 加仓 |
| 4 | ✓ | Eos Energy Enterprises Inc | +4.3% | +531.51% | 加仓 |
| 5 | ✓ | Volcon Inc | +3.7% | NEW | 新建仓 |
| 6 | HCWC | Healthy Choice Wellness CORP | +3.4% | NEW | 新建仓 |
| 7 | CLSNEUR | Imunon Inc | +2.9% | NEW | 新建仓 |
| 8 | ✓ | Spdr S&P 500 Etf Tr Put Option | +2.4% | +13.99% | 加仓 |
| 9 | CORZ | Core Scientific Inc | +1.8% | NEW | 新建仓 |
| 10 | SPY | State Street SPDR S&P 500 ETF Trust | +1.7% | +146.38% | 加仓 |
| 11 | ✓ | +1.7% | NEW | 新建仓 | |
| 12 | CORZ | Core Scientific, Inc. | +1.6% | -15.18% | 减仓 |
| 13 | SCPX | Scorpius Holdings Inc | +1.1% | NEW | 新建仓 |
| 14 | ✓ | Ensysce Biosciences Inc | +1.1% | +269.84% | 加仓 |
| 15 | ✓ | Checkpoint Therapeutics Inc | +1% | -34.97% | 减仓 |
| 16 | ✓ | +1% | NEW | 新建仓 | |
| 17 | SNES | Senestech Inc | +0.7% | NEW | 新建仓 |
| 18 | ✓ | +0.6% | NEW | 新建仓 | |
| 19 | ✓ | +0.6% | NEW | 新建仓 | |
| 20 | ATXI | Avenue Therapeutics Inc | +0.5% | +68.64% | 加仓 |
| 21 | ✓ | Nrx Pharmaceuticals Inc | +0.4% | +44.91% | 加仓 |
| 22 | PHIO | Phio Pharmaceuticals CORP | +0.4% | NEW | 新建仓 |
| 23 | NRXP | Nrx Pharmaceuticals Inc | +0.3% | NEW | 新建仓 |
| 24 | VVOS | Vivos Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 25 | ✓ | Bluejay Diagnostics Inc | +0.2% | NEW | 新建仓 |
| 26 | ✓ | Revelation Biosciences Inc | +0.2% | NEW | 新建仓 |
| 27 | ✓ | +0.2% | NEW | 新建仓 | |
| 28 | SIDU | Sidus Space Inc-cl A | +0.1% | -63.78% | 减仓 |
| 29 | KPRX | Kiora Pharmaceuticals Inc | +0.1% | NEW | 新建仓 |
| 30 | ✓ | Reviva Pharmaceutcls Hldgs Inc | +0.1% | NEW | 新建仓 |
| 31 | ✓ | Globus Maritime Limited New | +0.1% | — | 不变 |
| 32 | SXTPW | 60 Degrees Pharma Inc-28 | 0% | -8.28% | 减仓 |
| 33 | ✓ | 0% | NEW | 新建仓 | |
| 34 | AMPGW | Amplitech Group Inc-cw26 | 0% | -40.68% | 减仓 |
| 35 | ✓ | Scilex Holding Co | 0% | NEW | 新建仓 |
| 36 | SCLXUSD | Scilex Holding Co | 0% | NEW | 新建仓 |
| 37 | ✓ | 0% | NEW | 新建仓 | |
| 38 | ✓ | Atossa Therapeutics Inc | 0% | NEW | 新建仓 |
| 39 | ✓ | Wearable Devices LTD | 0% | -33.34% | 减仓 |
| 40 | ✓ | 0% | EXIT | 清仓 | |
| 41 | CINGW | Cingulate -cw23 | 0% | EXIT | 清仓 |
| 42 | ✓ | Applied Dna Sciences Inc | 0% | EXIT | 清仓 |
| 43 | SCNI | Scinai Immunotherapeutics Lt | -0.1% | EXIT | 清仓 |
| 44 | ✓ | Gevo Inc | -0.1% | EXIT | 清仓 |
| 45 | ✓ | China Natural Resources Inc | -0.1% | EXIT | 清仓 |
| 46 | ✓ | Inmed Pharmaceuticals Inc | -0.1% | EXIT | 清仓 |
| 47 | EFTR | Effector Therapeutics Inc | -0.1% | -82.46% | 减仓 |
| 48 | SMFL | Smart For Life Inc | -0.1% | EXIT | 清仓 |
| 49 | GEVO | Gevo Inc | -0.2% | EXIT | 清仓 |
| 50 | NEXI | Neximmune Inc | -0.2% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案,Sabby Management, LLC 在 Q3 2024 季度的美股持仓总市值约为 US$1.1亿,共申报了 42 个公开持股仓位。
在 Q3 2024 季度,Sabby Management, LLC 按市值排列的前三大核心持股分别为:CORE SCIENTIFIC INC NEW (40.5%)、VANI (11.3%)、BIT DIGITAL INC (10.0%)。其中最大持股仓位 CORE SCIENTIFIC INC NEW 占据整体投资组合约 40.5% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
VOLCON INC
市值: US$80.6万
本季最大获利了结 / 清仓标的
CORZW
前期市值: US$76.2万
在 Q3 2024 季度中,Sabby Management, LLC 共进行了 61 项持仓异动,包含新建仓 23 个仓位、加仓 10 个仓位、减仓 8 个仓位以及清仓 20 个仓位。 其中最大新建仓标的为 VOLCON INC。 本季清仓仓位包含 CORZW。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报,掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。